Clinical Trial Update: Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing raltegravir versus efavirenz combined with standard therapy in treatment-naïve HIV-1 patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Raltegravir (raltegravir)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED | Results posted: 2019-02-25